MEDICAL TECHNOLOGIES
Abstract
This program supports the development of field medical equipment, diagnostic capabilities and treatments; technologies to improve warfighter safety and to enhance personnel performance under adverse conditions; and systems to prevent occupational injury and disease in hazardous, deployment environments; including regenerative medicine technologies and therapeutic/restorative practices for the treatment of combat-related traumatic injuries. Navy investment in these areas is essential because Navy/USMC mission needs are not adequately addressed by the civilian sector or other Federal agencies. For example, civilian emergency medicine does not address casualty stabilization during long transit times to definitive care. The National Institutes of Health (NIH) focuses on the basic science of disease processes and not applied research related to development. Programs are coordinated with other Services through the Armed Services Biomedical Research Evaluation and Management (ASBREM) Committee, and Joint Technical Coordinating Group (JTCG) process, to prevent duplication of effort. The decrease of funding from FY 2012 to FY 2013 is the result of the transfer of resources from this R2 activity to a new FNC R2 activity titled Force Health Protection. Efforts in this R2 activity have been continued from FY 2012 to FY 2013 in the new R2 activity to support all FNC program EC Investments.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2014
- Source ID
- 8e87672801b8199f1172d773fc57e15d